These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7108550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
    Tanaka A, Takahashi Y, Mizokuchi M, Shimada N, Koide H.
    Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
    Kikuchi T, Orita Y, Ando A, Mikami H, Fujii M, Okada A, Abe H.
    Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
    [Abstract] [Full Text] [Related]

  • 8. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP, Robitaille P, Vanasse M, Qureshi IA, Marescau B.
    Nephron; 1995 Nov; 69(4):411-7. PubMed ID: 7777105
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy.
    Marescau B, De Deyn PP, Lowenthal A, Qureshi IA, Antonozzi I, Bachmann C, Cederbaum SD, Cerone R, Chamoles N, Colombo JP.
    Pediatr Res; 1990 Mar; 27(3):297-303. PubMed ID: 1690873
    [Abstract] [Full Text] [Related]

  • 11. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
    De Deyn P, Marescau B, Lornoy W, Becaus I, Van Leuven I, Van Gorp L, Lowenthal A.
    Nephron; 1987 Mar; 45(4):291-5. PubMed ID: 3587469
    [Abstract] [Full Text] [Related]

  • 12. Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.
    D'Hooge R, Pei YQ, Marescau B, De Deyn PP.
    J Neurol Sci; 1992 Oct; 112(1-2):96-105. PubMed ID: 1469446
    [Abstract] [Full Text] [Related]

  • 13. Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture.
    De Deyn PP, Macdonald RL.
    Ann Neurol; 1990 Nov; 28(5):627-33. PubMed ID: 2135950
    [Abstract] [Full Text] [Related]

  • 14. Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia.
    Deignan JL, De Deyn PP, Cederbaum SD, Fuchshuber A, Roth B, Gsell W, Marescau B.
    Mol Genet Metab; 2010 Nov; 100 Suppl 1():S31-6. PubMed ID: 20176499
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Significance of guanidino compounds in non-dialyzed patients with chronic renal failure.
    Ikezaki N.
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):283-90. PubMed ID: 2355664
    [Abstract] [Full Text] [Related]

  • 17. Measurement during convulsions of guanidino compound levels in cerebrospinal fluid collected with a catheter inserted into the cisterna magna of rabbits.
    Hiramatsu M, Edamatsu R, Fujikawa N, Shirasu A, Yamamoto M, Suzuki S, Mori A.
    Brain Res; 1988 Jul 05; 455(1):38-42. PubMed ID: 3416191
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
    De Deyn PP, Marescau B, Swartz RD, Hogaerth R, Possemiers I, Lowenthal A.
    Nephron; 1990 Jul 05; 54(4):307-12. PubMed ID: 2325795
    [Abstract] [Full Text] [Related]

  • 20. Anisoin: a useful pre-chromatographic derivatization fluorogenic reagent for LC analysis of guanidino compounds.
    Gatti R, Gioia MG.
    J Pharm Biomed Anal; 2006 Sep 11; 42(1):11-6. PubMed ID: 16460903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.